Low Vaccination Rates Among Older Americans Despite New R.S.V. Shots
Only about 15 percent of Americans over 60 have received one of the two new R.S.V. (respiratory syncytial virus) shots, which are the first-ever vaccines against the disease. This is in contrast to the more than 62 percent of adults over 65 who have received the recommended flu shot this fall and a third who have received the updated Covid-19 vaccine. The low vaccination rates for R.S.V. can be attributed to factors such as limited awareness, shared decision-making recommendations, and the challenge of promoting multiple seasonal vaccines. While the vaccines are highly effective, clear information and guidance are needed to improve uptake among older Americans.